Vera L G Calich Selected Research

Mycoses (Diseases, Fungus)

1/2021	Invariant Natural Killer T Cells as Key Players in Host Resistance against Paracoccidioides brasiliensis.
1/2021	AhR Ligands Modulate the Differentiation of Innate Lymphoid Cells and T Helper Cell Subsets That Control the Severity of a Pulmonary Fungal Infection.
1/2015	TLR-4 cooperates with Dectin-1 and mannose receptor to expand Th17 and Tc17 cells induced by Paracoccidioides brasiliensis stimulated dendritic cells.
9/2014	Dectin-1 induces M1 macrophages and prominent expansion of CD8+IL-17+ cells in pulmonary Paracoccidioidomycosis.
1/2013	TNF-α and CD8+ T cells mediate the beneficial effects of nitric oxide synthase-2 deficiency in pulmonary paracoccidioidomycosis.
3/2010	Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells.
6/2008	Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vera L G Calich Research Topics

Disease

15	Paracoccidioidomycosis (South American Blastomycosis) 12/2019 - 05/2002
14	Infections 01/2021 - 05/2002
7	Mycoses (Diseases, Fungus) 01/2021 - 06/2008
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2015 - 01/2015
2	Inflammation (Inflammations) 01/2015 - 11/2014
2	Hypersensitivity (Allergy) 05/2004 - 04/2004
1	Fungal Lung Diseases 01/2021
1	Neoplasms (Cancer) 01/2018
1	Coinfection 03/2007
1	Lung Diseases (Lung Disease) 07/2004
1	Pneumonia (Pneumonitis) 05/2002

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 09/2014 - 05/2002
5	dectin 1IBA 12/2019 - 09/2014
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2019 - 11/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013 - 05/2002
3	AntibodiesIBA 03/2010 - 05/2004
2	LigandsIBA 01/2021 - 01/2021
2	EnzymesIBA 12/2019 - 11/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019 - 06/2008
2	InflammasomesIBA 01/2017 - 01/2015
2	MannansIBA 01/2015 - 09/2014
2	SugarsIBA 01/2015 - 09/2014
2	GlucansIBA 01/2015 - 09/2014
2	Interleukin-12 (IL 12)IBA 04/2013 - 05/2002
2	Interleukin-4 (Interleukin 4)IBA 07/2004 - 04/2004
1	6-formylindolo(3,2-b)carbazoleIBA 01/2021
1	carbazoleIBA 01/2021
1	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA 01/2021
1	NLR ProteinsIBA 12/2019
1	MelatoninIBA 01/2018
1	VaccinesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Syk KinaseIBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 01/2017
1	Interferon Type IIBA 02/2015
1	LipoxinsIBA 01/2015
1	curdlanIBA 01/2015
1	lipoxin A4IBA 01/2015
1	LipidsIBA 01/2015
1	LeukotrienesIBA 01/2015
1	Leukotriene C4IBA 01/2015
1	laminaranIBA 01/2015
1	Pattern Recognition ReceptorsIBA 01/2015
1	Tryptophan (L-Tryptophan)FDA Link 11/2014
1	Messenger RNA (mRNA)IBA 11/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	Toll-Like Receptor 4IBA 03/2010
1	AntigensIBA 03/2007
1	Interferon-gamma (Interferon, gamma)IBA 07/2004
1	Monoclonal AntibodiesIBA 07/2004
1	Laminin (Merosin)IBA 05/2004
1	Interleukin-2 (IL2)IBA 04/2004
1	DNA (Deoxyribonucleic Acid)IBA 07/2002
1	Immunoglobulin G (IgG)IBA 05/2002

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
1	Immunotherapy 01/2018
1	Immunomodulation 04/2013